CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation
about
The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorHistone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formationZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcriptionPML promotes MHC class II gene expression by stabilizing the class II transactivatorThe zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcriptionInterleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytesSumoylation of the zinc finger protein ZXDC enhances the function of its transcriptional activation domainNew functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis studyThe nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activityMitogen-activated protein kinase ERK1/2 regulates the class II transactivatorNLRC5, at the Heart of Antigen PresentationTranscriptional and posttranscriptional regulations of the HLA-G geneThe RFX family interacts at the collagen (COL1A2) start site and represses transcriptionExpression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAPTwo distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domainsSelf-association of CIITA and its transactivation potential.A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promotersPromoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationPhosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform IIIProduction of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined MicrominipigsCATERPILLERs, pyrin and hereditary immunological disorders.CIITA and Its Dual Roles in MHC Gene Transcription.NLR functions in plant and animal immune systems: so far and yet so close.Expression regulation and function of NLRC5.Self-association of class II transactivator correlates with its intracellular localization and transactivation.NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X ComplexDownregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic linesDiscovery of a viral NLR homolog that inhibits the inflammasome.The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2.NLRP3 moonlights in TH2 polarization.
P2860
Q22330805-E4A64894-2482-45F7-8074-676E2C8EA510Q24289051-3FFD0D14-9B92-4107-9B92-BC260ADD2E46Q24289418-FF149B89-92FC-4CF6-A06D-6A932025B1DAQ24299467-8F96C7F0-BAB7-4EA0-AFEC-5C868E3DF266Q24305248-2BF23630-51A1-4C39-B318-C6337F59C123Q24317219-4E84B186-14CB-45A9-8745-B7831FF7EFC1Q24337359-6B6E80EB-F5B3-4731-9C13-16601B9C985DQ24534865-E755F915-8623-4E73-9978-864768ADE9F6Q24629389-5191F25F-651F-4B85-A01E-C5D3F54A1A70Q24652921-257D41FB-D511-4E89-993A-EC1558B7D71FQ26823400-E10A3FBD-C002-4430-81B9-F47C48C004A9Q27015092-318AACFB-ECBA-4301-B633-0F6A8A8DBD6CQ28216325-E1BF36DB-1ABB-4F9F-96A4-E61E1765D149Q28511541-1EB0FD6C-59C4-483C-9749-33027927CBD3Q33967979-5CB5EB36-3219-475C-8E61-389DEC21BFCFQ33969017-708D82EC-81D4-48EF-8039-4DC526867325Q34012543-3BE0EA86-DD90-4F51-84BE-96F26CEB796EQ34086182-38934D97-39C2-4338-A130-0ED1E40023D7Q34150349-D8CAD5D7-06A4-4945-B364-B9AAD40CD9CBQ35036496-71EB6883-A8FF-4779-BEDF-8B5293512E54Q35911960-9496F61A-41CC-4F22-8473-48B95F367DC5Q35922077-59513ADA-C2F7-43BB-B37E-C04106A46B1FQ36167875-70F4B8A9-F6D1-4A8E-A83C-E2D0AEEA62C3Q36405072-80C77E40-924A-4094-8F51-A9D7321CA4ABQ37405448-FDB26283-2E58-425F-9AAA-5857C70CDE63Q37919714-694CF2BC-3892-4400-A0FE-DF84C5063503Q38088676-CF806153-F0E2-42A7-B573-CC311E5564C1Q38299750-B77707A8-6C26-45C5-B2D3-30561B5ED1F2Q38710699-FCC354AA-921F-4DBC-95C7-3163FF0FDEF2Q38903379-0E8C22A4-FDF6-45A6-A359-54D5D608224FQ39459892-970282C7-2DA4-4A9D-A4E1-EF58C1D510B6Q39604966-F6347E60-5544-47F3-8681-05A4A8E547D9Q39695544-3EAF2254-E54D-4744-872A-EA511492B411Q39927810-6E3DC884-B1DD-4783-8AC7-A4A1C19A656CQ40532153-CB049A4F-41D5-4F72-8AED-6DEAABAE9791Q40699713-8743775C-B133-41AA-9D3E-9728153CF145Q40816207-307D7CF7-BD85-4056-8E82-866ECC40738EQ42156320-893F97CF-D8CD-45A7-885A-F9BD29D07BE3Q42613420-0360B81A-9FB6-4E73-AC02-0CA419D89D9DQ48156568-9C8F6B1C-3817-4421-98A5-8D94E1BCF518
P2860
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CIITA leucine-rich repeats con ...... class II gene transactivation
@ast
CIITA leucine-rich repeats con ...... class II gene transactivation
@en
CIITA leucine-rich repeats con ...... class II gene transactivation
@nl
type
label
CIITA leucine-rich repeats con ...... class II gene transactivation
@ast
CIITA leucine-rich repeats con ...... class II gene transactivation
@en
CIITA leucine-rich repeats con ...... class II gene transactivation
@nl
prefLabel
CIITA leucine-rich repeats con ...... class II gene transactivation
@ast
CIITA leucine-rich repeats con ...... class II gene transactivation
@en
CIITA leucine-rich repeats con ...... class II gene transactivation
@nl
P2093
P2860
P3181
P1476
CIITA leucine-rich repeats con ...... class II gene transactivation
@en
P2093
P2860
P304
P3181
P356
10.1128/MCB.20.20.7716-7725.2000
P407
P577
2000-10-01T00:00:00Z